Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antimetabolites | 1 | 2020 | 106 | 0.83 | Why? |
| Inferior Wall Myocardial Infarction | 1 | 2017 | 12 | 0.72 | Why? |
| Percutaneous Coronary Intervention | 7 | 2018 | 3646 | 0.69 | Why? |
| Hemoglobins | 2 | 2021 | 958 | 0.69 | Why? |
| Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 1645 | 0.68 | Why? |
| New York City | 8 | 2021 | 7432 | 0.64 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.62 | Why? |
| Troponin I | 2 | 2020 | 1298 | 0.58 | Why? |
| Contrast Media | 2 | 2018 | 1011 | 0.58 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.53 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.50 | Why? |
| Hospital Mortality | 13 | 2021 | 22087 | 0.50 | Why? |
| Thrombolytic Therapy | 2 | 2021 | 2218 | 0.46 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.42 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.41 | Why? |
| Cardiac Catheterization | 1 | 2018 | 882 | 0.41 | Why? |
| Transcatheter Aortic Valve Replacement | 4 | 2019 | 839 | 0.40 | Why? |
| Coronary Artery Disease | 3 | 2020 | 2570 | 0.38 | Why? |
| Atrial Fibrillation | 2 | 2020 | 2320 | 0.37 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.35 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.33 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.31 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.31 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.31 | Why? |
| Postoperative Complications | 3 | 2019 | 5861 | 0.30 | Why? |
| Mitral Valve | 2 | 2019 | 342 | 0.29 | Why? |
| Palliative Care | 1 | 2020 | 2665 | 0.29 | Why? |
| Steroids | 2 | 2021 | 904 | 0.29 | Why? |
| Heart Valve Diseases | 2 | 2019 | 355 | 0.28 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.27 | Why? |
| Aortic Valve | 3 | 2019 | 664 | 0.27 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.27 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.27 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.26 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.24 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.23 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.23 | Why? |
| Aged | 22 | 2021 | 215776 | 0.21 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2021 | 191 | 0.21 | Why? |
| Odds Ratio | 3 | 2021 | 5861 | 0.21 | Why? |
| Catheters | 2 | 2017 | 93 | 0.21 | Why? |
| Prodromal Symptoms | 1 | 2020 | 133 | 0.20 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.19 | Why? |
| Humans | 43 | 2021 | 930598 | 0.19 | Why? |
| Advance Directives | 1 | 2020 | 112 | 0.19 | Why? |
| Acute Coronary Syndrome | 3 | 2017 | 2107 | 0.19 | Why? |
| Female | 24 | 2021 | 380317 | 0.19 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.19 | Why? |
| Male | 27 | 2021 | 367725 | 0.18 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.18 | Why? |
| Tricuspid Valve | 1 | 2019 | 91 | 0.18 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.18 | Why? |
| Cold Temperature | 1 | 2019 | 260 | 0.18 | Why? |
| Coronary Vasospasm | 1 | 2017 | 36 | 0.17 | Why? |
| Angina, Stable | 1 | 2017 | 45 | 0.17 | Why? |
| Medical Records | 1 | 2020 | 513 | 0.17 | Why? |
| Aortic Aneurysm | 1 | 2019 | 121 | 0.17 | Why? |
| Risk Factors | 11 | 2021 | 71621 | 0.17 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.16 | Why? |
| Weather | 2 | 2020 | 581 | 0.16 | Why? |
| Electronic Health Records | 2 | 2020 | 3492 | 0.16 | Why? |
| Radial Artery | 1 | 2018 | 132 | 0.16 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Conjunctivitis, Viral | 1 | 2020 | 301 | 0.15 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.14 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.14 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.14 | Why? |
| Administration, Inhalation | 1 | 2021 | 1647 | 0.14 | Why? |
| Tissue Plasminogen Activator | 1 | 2021 | 778 | 0.14 | Why? |
| Aneurysm, Dissecting | 1 | 2019 | 303 | 0.14 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.14 | Why? |
| Mitral Valve Insufficiency | 1 | 2018 | 302 | 0.14 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.14 | Why? |
| Rivaroxaban | 1 | 2018 | 467 | 0.13 | Why? |
| Peripheral Arterial Disease | 1 | 2020 | 471 | 0.13 | Why? |
| Mycoses | 1 | 2020 | 589 | 0.13 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 634 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2021 | 253789 | 0.13 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.13 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2019 | 552 | 0.12 | Why? |
| Ultrasonography, Interventional | 2 | 2017 | 560 | 0.12 | Why? |
| Pericarditis | 1 | 2018 | 417 | 0.12 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.12 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.12 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Coronary Occlusion | 1 | 2013 | 138 | 0.11 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.11 | Why? |
| Robotic Surgical Procedures | 1 | 2019 | 787 | 0.11 | Why? |
| Aortic Valve Stenosis | 1 | 2019 | 741 | 0.11 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.11 | Why? |
| Ultraviolet Rays | 1 | 2020 | 1272 | 0.11 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.11 | Why? |
| Cardiomyopathies | 1 | 2020 | 997 | 0.10 | Why? |
| Coronary Angiography | 2 | 2017 | 2275 | 0.10 | Why? |
| Coronary Thrombosis | 1 | 2015 | 433 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2013 | 365 | 0.10 | Why? |
| Blood Transfusion | 1 | 2019 | 1399 | 0.10 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.09 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.08 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.08 | Why? |
| Bacterial Infections | 1 | 2020 | 2229 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2020 | 1876 | 0.08 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.07 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Japan | 4 | 2018 | 6653 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.07 | Why? |
| Thrombectomy | 1 | 2015 | 2272 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Regression Analysis | 2 | 2020 | 2484 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.06 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.06 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.06 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2017 | 3051 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Cities | 2 | 2020 | 4937 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| No-Reflow Phenomenon | 1 | 2017 | 14 | 0.04 | Why? |
| Registries | 4 | 2018 | 12327 | 0.04 | Why? |
| Postoperative Hemorrhage | 1 | 2019 | 183 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Hypothermia, Induced | 1 | 2017 | 176 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.03 | Why? |
| Collateral Circulation | 1 | 2013 | 56 | 0.03 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Anemia | 1 | 2019 | 789 | 0.03 | Why? |
| Coronary Circulation | 1 | 2013 | 188 | 0.03 | Why? |
| Income | 1 | 2020 | 1564 | 0.03 | Why? |
| Propensity Score | 1 | 2019 | 2690 | 0.03 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2019 | 1555 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.02 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Radiography | 1 | 2013 | 1576 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| United States | 2 | 2020 | 46150 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Equipment Design | 1 | 2013 | 3095 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Sex Factors | 1 | 2016 | 11014 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
Kuno's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_